Skip to content
View original post on X: 🚨 AI News | TestingCatalog
Published
59/100

OpenAI acquires Orchestra Bio to build on its Rosalind life-sciences models

AIOpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate drug development. OpenAI says it will build on Rosalind, its AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
@testingcatalog
View on X

OpenAI ❤️ Orchestra Bio

OpenAI has acquired Orchestra Bio⁠ to work on Rosalind models and tools for life sciences research.

"Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."

AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.

OpenAI@OpenAI
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/
View quoted post on X
Source details

🚨 AI News | TestingCatalog · x.comPublished

Original title: OpenAI ❤️ Orchestra Bio